HRT Financial’s Anbio Biotechnology NNNN Stock Holding History

HRT Financial’s Portfolio NNNN Stock Details NNNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,013	Closed	-$223K	–	4287
2025 Q3	$223K	Buy	+6,013	New	+$270K	﹤0.01%	2357

Other funds holding NNNN

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial's NNNN Position: Q4 2025 in Review

HRT Financial sold out of Anbio Biotechnology (NNNN) in Q4 2025, closing a stake of 6,013 shares — an estimated $223K sold.

HRT Financial first reported a position in NNNN in Q3 2025 and held it in 1 quarter. The position peaked at $223K in Q3 2025. 5 funds tracked by Wall St. Rank hold NNNN as of Q4 2025.

HRT Financial reported no remaining Anbio Biotechnology position as of Q4 2025 after selling out during the quarter.
HRT Financial sold 6,013 Anbio Biotechnology shares in Q4 2025, an estimated $223K.
HRT Financial first reported a position in Anbio Biotechnology in Q3 2025 and held it in 1 quarter.
HRT Financial's Anbio Biotechnology position peaked at $223K in Q3 2025.
5 funds tracked by Wall St. Rank held Anbio Biotechnology as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.